المؤلفون: I. M. Kagantsov, A. A. Sukhotskaya, A. A. Shcherbakov, M. G. Vitovshchik, O. M. Vorobyeva, P. A. Ryazanov, Yu. V. Dinikina, T. M. Pervunina, И. М. Каганцов, А. А. Сухоцкая, А. А. Щербаков, М. Г. Витовщик, О. М. Воробьева, П. А. Рязанов, Ю. В. Диникина, Т. М. Первунина

المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 9, № 1 (2022); 52-59 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 9, № 1 (2022); 52-59 ; 2413-5496 ; 2311-1267

مصطلحات موضوعية: оперативное лечение, children, surgical treatment, дети

وصف الملف: application/pdf

العلاقة: https://journal.nodgo.org/jour/article/view/802/719Test; Reye R.D. A consideration of certain subdermal fibromatous tumours of infancy. J Pathol Bacteriol. 1956;72(1):149–54. doi:10.1002/path.1700720120.; Enzinger F.M. Fibrous hamartoma of infancy. Cancer. 1965;18:241–8. doi:10.1002/1097-0142(196502)18:23.0.co;2-c.; Yu G., Wang Y., Wang G., Zhang D., Sun Y. Fibrous hamartoma of infancy: a clinical pathological analysis of seventeen cases. Int J Clin Exp Pathol. 2015;8(3):3374–7. PMID: 26045872.; Al-Ibraheemi A., Martinez A., Weiss S.W., Kozakewich H.P., Perez-Atayde A.R., Tran H., Parham D.M., Sukov W.R., Fritchie K.J., Folpe A.L. Fibrous hamartoma of infancy: a clinicopathologic study of 145 cases, including 2 with sarcomatous features. Mod Pathol. 2017;30(4):474–85. doi:10.1038/modpathol.2016.215.; Carretto E., DallʼIgna P., Alaggio R., Siracusa F., Granata C., Ferrari A., Cecchetto G. Fibrous hamartoma of infancy: an Italian multi-institutional experience. J Am Acad Dermatol. 2006;54(5):800–3. doi:10.1016/j.jaad.2005.11.1076.; Efem S.E., Ekpo M.D. Clinicopathological features of untreated fibrous hamartoma of infancy. J Clin Pathol. 1993;46(6):522–4. doi:10.1136/jcp.46.6.522.; Coffin C.M., Alaggio R. Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol. 2012;15(1 Suppl):127–80. doi:10.2350/10-12-0944-PB.1.; Dickey G.E., Sotelo-Avila C. Fibrous hamartoma of infancy: current review. Pediatr Dev Pathol. 1999;2(3):236–43. doi:10.1007/s100249900119.; Stensby J.D., Conces M.R., Nacey N.C. Benign fibrous hamartoma of infancy: a case of MR imaging paralleling histologic fi ndings. Skeletal Radiol. 2014;43(11):1639–43. doi:10.1007/s00256-014-1940-4.; Ji Y., Hu P., Zhang C., Yan Q., Cheng H., Han M., Huang Z., Wang X., Li H., Han Y. Fibrous hamartoma of infancy: radiologic features and literature review. BMC Musculoskelet Disord. 2019;3;20(1):356. doi:10.1186/s12891-019-2743-5.; Lee S., Choi Y.H., Cheon J.E., Kim M.J., Lee M.J., Koh M.J. Ultrasonographic features of fibrous hamartoma of infancy. Skeletal Radiol. 2014;43(5):649–53. doi:10.1007/s00256-014-1838-1.; Imaji R., Goto T., Takahashi Y., Akiyama T., Yamadori I. A case of recurrent and synchronous fibrous hamartoma of infancy. Pediatr Surg Int. 2005;21(2):119–20. doi:10.1007/s00383-004-1357-6.; Yano S., Hida K., Nagashima K., Iwasaki Y. Spinal fibrous hamartoma of infancy: case report. Neurosurgery. 2004;55(3):712. doi:10.1227/01.neu.0000134614.73236.a4.; Arioni C., Bellini C., Oddone M., Risso F.M., Scopesi F., Nozza P., Serra G., Tomà P. Congenital fibrous hamartoma of the knee. Pediatr Radiol. 2006;36(5):453–5. doi:10.1007/s00247-006-0126-1.; You M.H., Shin D.H., Choi J.S., Kim B.S., Kim Y., Kim J. The First Reported Case of Fibrous Hamartoma of Infancy with Hyperhidrosis and Hypertrichosis in Korea. J Korean Med Sci. 2018;33(9):e66. doi:10.3346/jkms.2018.33.e66.; Stepančec H., Kokot Z., Keretić D., Radiković S., Grgurović D. Fibrous Hamartoma of Infancy in the Scrotum. European J Pediatr Surg Rep. 2019;7(1):e100–3. doi:10.1055/s-0039-1697924.; Wang S., Ma Q., Ying H., Jiao Q., Yang D., Zhang B., Zhao L. Giant fibrous hamartoma of infancy: A case report. Medicine (Baltimore). 2020;99(11):e19489. doi:10.1097/MD.0000000000019489.; Miroux-Catarino A., Claro C., Viana I. Giant fibrous hamartoma of infancy: pitfall of CD34 positive dermal mesenchymal tumor. Dermatol Online J. 2018;24(6):13030/qt160398hv. PMID: 30142714.; Sehgal M., Anand S., Dhua A.K., Yadav D.K., Arava S., Barwad A. Rare Paratesticular Masses in Children. J Indian Assoc Pediatr Surg. 2021;26(2):117–9. doi:10.4103/jiaps.JIAPS_182_19.; Agrawal L., Bansal R., Singh J., Sharma S. Fibrous hamartoma of infancy in an unusual location – a case report. Gulf J Oncolog. 2010;(8):52–4. PMID: 20601341.; Шароев Т.А., Сухарев А.В., Иванова Н.М., Климчук О.В., Рощин В.Ю. Инфантильная фибросаркома мягких тканей бедра у ребенка 3 месяцев. Российский вестник детской хирургии, анестезиологии и реаниматологии. 2014;4(2):81–6.; https://journal.nodgo.org/jour/article/view/802Test

الإتاحة: https://doi.org/10.21682/2311-1267-2022-9-1-52-59Test
https://doi.org/10.1002/path.1700720120Test
https://doi.org/10.1002/1097-0142Test(196502)18:2<241::aid-cncr2820180216>3.0.co;2-c
https://doi.org/10.1038/modpathol.2016.215Test
https://doi.org/10.1016/j.jaad.2005.11.1076Test
https://doi.org/10.1136/jcp.46.6.522Test
https://doi.org/10.2350/10-12-0944-PB.1Test
https://doi.org/10.1007/s100249900119Test
https://doi.org/10.1007/s00256-014-1940-4Test
https://doi.org/10.1186/s12891-019-2743-5Test

المؤلفون: E. I. Konopleva, D. V. Shevtsov, G. R. Kazaryan, A. M. Suleymanova, D. S. Abramov, D. G. Akhaladze, A. P. Shcherbakov, A. E. Druy, E. V. Kazaryan, T. V. Shamanskaya, D. Yu. Kachanov, S. R. Varfolomeeva, Е. И. Коноплева, Д. В. Шевцов, Г. Р. Казарян, А. М. Сулейманова, Д. С. Абрамов, Д. Г. Ахаладзе, А. П. Щербаков, А. Е. Друй, Э. В. Казарян, Т. В. Шаманская, Д. Ю. Качанов, С. Р. Варфоломеева

المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 7, № 3 (2020); 112-118 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 7, № 3 (2020); 112-118 ; 2413-5496 ; 2311-1267 ; 10.21682/2311-1267-2020-7-3

مصطلحات موضوعية: эпителиальные опухоли тимуса, thymic carcinoma, thymic epithelial tumors, карцинома тимуса

وصف الملف: application/pdf

العلاقة: https://journal.nodgo.org/jour/article/view/634/580Test; Engels E.A. Epidemiology of thymoma and associated malignancies. J Thorac Oncol 2010;5(10 suppl 4):260–5. doi:10.1097/JTO.0b013e3181f1f62d.; Ruffini E., Detterbeck F., Van Raemdonck D., Rocco G., Thomas P., Weder W., Brunelli A., Guererra F., Keshavjee S., Altorki N., Schutznerr J., Arame A., Spaggiari L., Lim E., Toker A., Venuta F. Thymic carcinoma: a cohort study of patients from the European Society of Thoracic Surgeons database. J Thorac Oncol 2014;9(4):541–8. doi:10.1097/JTO.0000000000000128.; Stachowicz-Stencel T., Orbach D., Brecht I., Schneider D., Bien E., Synakiewicz A., Rod J., Ferrari A., Cecchetto G., Bisogno G. Thymoma and Thymic Carcinoma in Children and Adolescents: A Report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT). Eur J Cancer 2015;51(16):2444–52. doi:10.1016/j.ejca.2015.06.121.; Sekihara K., Okuma Y., Kawamoto H., Hosomi Y. Clinical Outcome of Thymic Lymphoepithelioma-like Carcinoma: Case Report of a 14-Year-Old Male. Oncol Lett 2014;8(5):2183–6. doi:10.3892/ol.2014.2475.; Girard N., Ruffini E., Marx A., Faivre-Finn C., Peters S. Thymic Epithelial Tumours: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Ann Oncol 2015;26 Suppl 5:40–55. doi:10.1093/annonc/mdv277.; Travis W., Brambilla E., Burke A., Marx A., Nicholson A. WHO classification of tumours of the lung, pleura, thymus and heart. IARC Press, 2015.; Rosai J., Sobin L. Histological Typing of Tumours of the Thymus. Springer, Berlin, Heidelberg, 1999.; Kojima Y., Ito H., Hasegawa S., Sasaki T., Inui K. Resected invasive thymoma with multiple endocrine neoplasia type 1. Jpn J Thorac Caridovasc Surg 2006;54(4):171–3. doi:10.1007/BF02662474.; Hsueh C., Kue T., Tsang N., Wu Y., Yang C., Hung I. Thymic Lymphoepitheliomalike Carcinoma in Children: Clinicopathologic Features and Molecular Analysis. J Pediatr Hematol Oncol 2006;28(12):785–90. doi:10.1097/MPH.0b013e31802d3a83.; Evoli A., Lancaster E. Paraneoplastic disorders in thymoma patients. J Thorac Oncol 2014;9(9):143–7. doi:10.1097/JTO.0000000000000300.; Chen G., Marx A., Wen-Hu C., Yong J., Puppe B., Stroebel P., MuellerHermlink H. New WHO histologic classifıcation predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002;95(2):420–9. doi:10.1002/cncr.10665.; Kondo K., Monden Y. Therapy for Thymic Epithelial Tumors: A Clinical Study of 1,320 Patients from Japan. Ann Thorac Surg 2003;76(3):878–84. https://doi.org/10.1016/S0003-4975Test(03)00555-1.; Stachowicz-Stencel T., Bien E., Balcerska A., Godzinski J., Synakiewicz A., Madziara W., Perek-Polnik M., Peregud-Pogorzelski J., Pietras W., Pobudejska A., Kurylak A., Mankowski P. Thymic carcinoma in children: a report from the Polish Pediatric Rare Tumors Study. Pediatr Blood Cancer 2010;54(7):916–20. doi:10.1002/pbc.22482.; Carretto E., Inserra A., Ferrari A., Conte M., Di Cataldo A., Migliorati R., Cecchetto G., Bisogno G. Epithelial thymic tumours in paediatric age: a report from the TREP project. Orphanet J Rare Dis 2011;5(21):6–28. doi:10.1186/1750-1172-6-28.; Litvak A., Woo K., Hayes S., Huang J., Rimner A., Sima C., Moreira A., Tsukazan M., Riely G. Clinical Characteristics and Outcomes for Patients With Thymic Carcinoma: Evaluation of Masaoka Staging. J Thorac Oncol 2014;9(12):1810–5. doi:10.1097/JTO.0000000000000363.; National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Thymomas and Thymic Carcinomas 2.2019. 2019 Mar 11. National Comprehensive Cancer Network. Abstract available at https://www.nccn.org/professionals/physician_gls/pdf/thymic.pdfTest.; Lemma G., Lee J., Aisner S., Langer C., Tester W., Johnson D., Loehrer P. Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma. J Clin Oncol 2011;29(15):2060–5. doi:10.1200/JCO.2010.32.9607.; Hirai F., Yamanaka T., Taguchi T., Daga H., Ono A., Tanaka K., Kogure Y., Shimizu J., Kimura T., Fukuoka J., Iwamoto Y., Sasaki H., Takeda K., Seto T., Ichinose Y., Nakagawa K., Nakanishi Y. A Multicenter Phase II Study of Carboplatin and Paclitaxel for Advanced Thymic Carcinoma: WJOG4207L. Ann Oncol 2015;26(2):363–8. doi:10.1093/annonc/mdu541.; Petrini I., Zucali P., Lee H., Pineda M., Meltzer P., Walter-Rodriguez B., Roncalli M., Santoro A., Wang Y, Giaccone G. Expression and mutational status of c-Kit in thymic epithelial tumors. J Thorac Oncol 2010;5(9):1447–53 doi:10.1097/JTO.0b013e3181e96e30.; Thomas A., Rajan A., Berman A., Tomita Y., Brzezniak C., Lee M., Lee S., Ling A., Spittler A., Carter C., Guha U., Wang Y., Szabo E., Meltzer P., Steinberg S., Trepel J., Loehrer P., Giaccone G. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet Oncol 2015;16(2):177–86. doi:10.1016/S1470-2045(14)71181-7.; Giaccone G., Kim C., Thompson J., McGuire C., Kallakury B., Chahine J., Manning M., Mogg R., Blumenschein W., Tan M., Subramaniam D., Liu S., Kaplan I., McCutcheon J. Articles Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. Lancet Oncol 2018;19(3):347–55. doi:10.1016/S1470-2045(18)30062-7.; https://journal.nodgo.org/jour/article/view/634Test

الإتاحة: https://doi.org/10.21682/2311-1267-2020-7-3-112-118Test
https://doi.org/10.21682/2311-1267-2020-7-3Test
https://doi.org/10.1097/JTO.0b013e3181f1f62dTest
https://doi.org/10.1097/JTO.0000000000000128Test
https://doi.org/10.1016/j.ejca.2015.06.121Test
https://doi.org/10.3892/ol.2014.2475Test
https://doi.org/10.1093/annonc/mdv277Test
https://doi.org/10.1007/BF02662474Test
https://doi.org/10.1097/MPH.0b013e31802d3a83Test
https://doi.org/10.1097/JTO.0000000000000300Test

المؤلفون: T. V. Sergeeva, D. Yu. Kachanov, Т. V. Shamanskaya, A. P. Shcherbakov, G. V. Tereshchenko, N. N. Merkulov, S. R. Talypov, V. Yu. Roshchin, D. M. Konovalov, S. R. Varfolomeeva, Т. В. Сергеева, Д. Ю. Качанов, Т. В. Шаманская, А. П. Щербаков, Г. В. Терещенко, Н. Н. Меркулов, С. Р. Талыпов, В. Ю. Рощин, Д. М. Коновалов, С. Р. Варфоломеева

المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 4, № 3 (2017); 97-101 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 4, № 3 (2017); 97-101 ; 2413-5496 ; 2311-1267 ; 10.17650/2311-1267-2017-4-3

وصف الملف: application/pdf

العلاقة: https://journal.nodgo.org/jour/article/view/324/323Test; Messinger Y.H., Stewart D.R., Priest J.R. et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer 2015;121(2):276–85. doi:10.1002/ cncr.29032.; Dehner L.P., Watterson J., Priest J.R. Pleuropulmonary blastoma. A unique intrathoracic-pulmonary neoplasm of childhood. Perspectives in Pediatric Pathology 1995;18:214–26.; Priest J.R., Watterson J., Strong L. et al. Pleuropulmonary blastoma: a marker for familial disease. J Pediatr 1996;128(2):220–4. PMID: 8636815.; Calabria R., Srikanth M.S., Chamberlin K., Bloch J., Atkinson J.B. Management of pulmonary blastoma in children. Am Surg 1993;59(3):192–6. PMID: 8476159.; Wright J.R. Pleuropulmonary blastoma: A case report documenting transition from type I (cystic) to type III (solid). Cancer 2000;88(12):2853–8. PMID: 10870072.; Priest J.R., Hill D.A., Williams G.M. et al. Type I pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry. J Clin Oncol 2006;24(27):4492–8. doi:10.1200/ JCO.2005.05.3595.; Priest J.R., Williams G.M., Hill D.A., Dehner L.P., Jaffé A. Pulmonary cysts in early childhood and the risk of malignancy. Pediatr Pulmonol 2009;44(1):14–30. doi:10.1002/ppul.20917.; Hill D.A., Ivanovich J., Priest J.R. et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009;325(5943):965. doi:10.1126/science.1174334.; Feinberg A., Hall N.J., Williams G.M. et al. Can congenital pulmonary airway malformation be distinguished from Type I pleuropulmonary blastoma based on clinical and radiological features? J Pediatr Surg 2016;51(1):33–7. doi:10.1016/j.jpedsurg.2015.10.019.; https://journal.nodgo.org/jour/article/view/324Test

الإتاحة: https://doi.org/10.17650/2311-1267-2017-4-3-97-101Test
https://doi.org/10.17650/2311-1267-2017-4-3Test
https://doi.org/10.1002/ppul.20917Test
https://doi.org/10.1126/science.1174334Test
https://journal.nodgo.org/jour/article/view/324Test

المؤلفون: T. V. Shamanskaya, D. Yu. Kachanov, Yu. N. Likar, A. P. Shcherbakov, S. R. Varfolomeeva, Т. В. Шаманская, Д. Ю. Качанов, Ю. Н. Ликарь, А. П. Щербаков, С. Р. Варфоломеева

المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 3, № 4 (2016); 91-95 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 3, № 4 (2016); 91-95 ; 2413-5496 ; 2311-1267 ; 10.17650/2311-1267-2016-3-4

مصطلحات موضوعية: сцинтиграфия костей скелета с бисфосфонатами, neuroblastoma, stage 4S, stage 4, scintigraphy with 123I meta-iodobenzylguanidine, skeletal scintigraphy with bisphosphonates, нейробластома, 4S стадия, 4-я стадия, сцинтиграфия с 123I-метайодбензилгуанидином

وصف الملف: application/pdf

العلاقة: https://journal.nodgo.org/jour/article/view/270/270Test; Cheung N.K., Dyer M.A. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 2013;13(6):397–411.; Качанов Д.Ю., Шаманская Т.В., Муфтахова Г.М., Варфоломеева С.Р. Нейробластома 4S стадии. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2014;13(2):9–19. [Kachanov D.Yu., Shamanskaya T.V., Muftakhova G.M., Varfolomeeva S.R. Stage 4S neuroblastoma. Voprosy gematologii/onkologii i immunopatologii v pediatrii = Pediatric Hematology/Oncology and Immunopathology 2014;13(2):9–19. (In Russ.)].; Kushner B.H. Neuroblastoma: A disease requiring a multitude of imaging studies. J Nucl Med 2004;4:1172–88.; Rufini V., Shulkin B. The evolution in the use of MIBG in more than 25 years of experimental and clinical applications. Q J Nucl Med Mol Imaging 2008;52(4):341–50.; Brisse H.J., McCarville M.B., Granata S. et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011;261:243–57.; Mueller W.P., Coppenrath E., Pfluger T. Nuclear medicine and multimodality imaging of pediatric neuroblastoma. Pediatr Radiol 2013;43:418–27.; Monclair T., Brodeur G.M., Ambros P.F. et al. INRG Task Force. The International Neuroblastoma Risk Group (INRG) staging system: An INRG Task Force report. J Clin Oncol 2009;27:298–303.; Shulkin B.L., Shapiro B. Current concepts on the diagnostic use of MIBG in children. J Nucl Med 1998;39:679–88.; De Bernardi B., Gerrard M., Boni L. et al. Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification. J Clin Oncol 2009;27(7):1034–40.; https://journal.nodgo.org/jour/article/view/270Test

الإتاحة: https://doi.org/10.17650/2311-1267-2016-3-4-91-95Test
https://doi.org/10.17650/2311-1267-2016-3-4Test
https://journal.nodgo.org/jour/article/view/270Test